These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34755397)

  • 1. The effects of levodopa in the spatiotemporal gait parameters are mediated by self-selected gait speed in Parkinson's disease.
    Ávila de Oliveira J; Bazán PR; de Oliveira CEN; Treza RC; Hondo SM; Los Angeles E; Bernardo C; de Oliveira LDS; Carvalho MJ; de Lima-Pardini AC; Coelho DB
    Eur J Neurosci; 2021 Dec; 54(11):8020-8028. PubMed ID: 34755397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recuperation of slow walking in de novo Parkinson's disease is more closely associated with increased cadence, rather than with expanded stride length.
    Kwon KY; Lee HM; Kang SH; Pyo SJ; Kim HJ; Koh SB
    Gait Posture; 2017 Oct; 58():1-6. PubMed ID: 28692855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levodopa alters resting-state functional connectivity more selectively in Parkinson's disease with freezing of gait.
    Potvin-Desrochers A; Atri A; Moreno AM; Paquette C
    Eur J Neurosci; 2023 Jan; 57(1):163-177. PubMed ID: 36251568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of levodopa on forward and backward gait patterns in persons with Parkinson's disease.
    Bryant MS; Rintala DH; Hou JG; Lai EC; Protas EJ
    NeuroRehabilitation; 2011; 29(3):247-52. PubMed ID: 22142758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-dimensional gait biomechanics in Parkinson's disease: evidence for a centrally mediated amplitude regulation disorder.
    Morris M; Iansek R; McGinley J; Matyas T; Huxham F
    Mov Disord; 2005 Jan; 20(1):40-50. PubMed ID: 15390033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting dopa-sensitive and dopa-resistant gait dysfunction in Parkinson's disease: selective responses to internal and external cues.
    Rochester L; Baker K; Nieuwboer A; Burn D
    Mov Disord; 2011 Feb; 26(3):430-5. PubMed ID: 21462258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gait variability in Parkinson's disease: levodopa and walking direction.
    Bryant MS; Rintala DH; Hou JG; Collins RL; Protas EJ
    Acta Neurol Scand; 2016 Jul; 134(1):83-6. PubMed ID: 26399376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variability in spatiotemporal gait characteristics over the course of the L-dopa cycle in people with advanced Parkinson disease .
    MacKay-Lyons M
    Phys Ther; 1998 Oct; 78(10):1083-94. PubMed ID: 9781702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gait variability in Parkinson's disease: an indicator of non-dopaminergic contributors to gait dysfunction?
    Lord S; Baker K; Nieuwboer A; Burn D; Rochester L
    J Neurol; 2011 Apr; 258(4):566-72. PubMed ID: 21052710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of gait and speech in Parkinson's disease: hypokinetic or dysrhythmic disorders?
    Cantiniaux S; Vaugoyeau M; Robert D; Horrelou-Pitek C; Mancini J; Witjas T; Azulay JP
    J Neurol Neurosurg Psychiatry; 2010 Feb; 81(2):177-84. PubMed ID: 19793764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anxiety-provoked gait changes are selectively dopa-responsive in Parkinson's disease.
    Ehgoetz Martens KA; Ellard CG; Almeida QJ
    Eur J Neurosci; 2015 Aug; 42(4):2028-35. PubMed ID: 25899750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic therapy and prefrontal activation during walking in individuals with Parkinson's disease: does the levodopa overdose hypothesis extend to gait?
    Dagan M; Herman T; Bernad-Elazari H; Gazit E; Maidan I; Giladi N; Mirelman A; Manor B; Hausdorff JM
    J Neurol; 2021 Feb; 268(2):658-668. PubMed ID: 32902733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gait variability in Parkinson's disease: influence of walking speed and dopaminergic treatment.
    Bryant MS; Rintala DH; Hou JG; Charness AL; Fernandez AL; Collins RL; Baker J; Lai EC; Protas EJ
    Neurol Res; 2011 Nov; 33(9):959-64. PubMed ID: 22080998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levodopa facilitates improvements in gait kinetics at the hip, not the ankle, in individuals with Parkinson's disease.
    Baudendistel ST; Schmitt AC; Roemmich RT; Harrison IL; Hass CJ
    J Biomech; 2021 May; 121():110366. PubMed ID: 33873118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gait dynamics in Parkinson's disease: relationship to Parkinsonian features, falls and response to levodopa.
    Schaafsma JD; Giladi N; Balash Y; Bartels AL; Gurevich T; Hausdorff JM
    J Neurol Sci; 2003 Aug; 212(1-2):47-53. PubMed ID: 12809998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Objective Gait and Balance Impairments Relate to Balance Confidence and Perceived Mobility in People With Parkinson Disease.
    Curtze C; Nutt JG; Carlson-Kuhta P; Mancini M; Horak FB
    Phys Ther; 2016 Nov; 96(11):1734-1743. PubMed ID: 27149959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gait Characteristics under Imposed Challenge Speed Conditions in Patients with Parkinson's Disease During Overground Walking.
    Lee M; Youm C; Noh B; Park H; Cheon SM
    Sensors (Basel); 2020 Apr; 20(7):. PubMed ID: 32290054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prefrontal Cortex Activity and Gait in Parkinson's Disease With Cholinergic and Dopaminergic Therapy.
    Stuart S; Morris R; Giritharan A; Quinn J; Nutt JG; Mancini M
    Mov Disord; 2020 Nov; 35(11):2019-2027. PubMed ID: 32830901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral neurostimulation breaks the shuffling steps patterns in Parkinsonian gait: a double blind randomized longitudinal study with automated mechanical peripheral stimulation.
    Galli M; Vicidomini C; Rozin Kleiner AF; Vacca L; Cimolin V; Condoluci C; Stocchi F; De Pandis MF
    Eur J Phys Rehabil Med; 2018 Dec; 54(6):860-865. PubMed ID: 29457707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Cost of Gait Slowness: Can Persons with Parkinson's Disease Save Energy by Walking Faster?
    Padmanabhan P; Sreekanth Rao K; Gonzalez AJ; Pantelyat AY; Chib VS; Roemmich RT
    J Parkinsons Dis; 2021; 11(4):2073-2084. PubMed ID: 34511512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.